These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23389603)

  • 1. Developing countries can contribute to global health innovation.
    Chakma J; Chakma H
    Nat Med; 2013 Feb; 19(2):129. PubMed ID: 23389603
    [No Abstract]   [Full Text] [Related]  

  • 2. Global health needs to fill the innovation gap.
    Mundel T
    Nat Med; 2012 Dec; 18(12):1735. PubMed ID: 23223055
    [No Abstract]   [Full Text] [Related]  

  • 3. New frontiers for collaborative research.
    Goldman M
    Sci Transl Med; 2013 Dec; 5(216):216ed22. PubMed ID: 24353157
    [No Abstract]   [Full Text] [Related]  

  • 4. Academic-industry partnerships 2012.
    Huggett B
    Nat Biotechnol; 2013 May; 31(5):383. PubMed ID: 23657385
    [No Abstract]   [Full Text] [Related]  

  • 5. Brain wave hits California.
    Shen H
    Nature; 2014 Jun; 510(7506):456. PubMed ID: 24965632
    [No Abstract]   [Full Text] [Related]  

  • 6. Dengue Vaccines: A Perspective from the Point of View of Intellectual Property.
    da Veiga CP; da Veiga CR; Del Corso JM; da Silva WV
    Int J Environ Res Public Health; 2015 Aug; 12(8):9454-74. PubMed ID: 26274968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schrödinger's pipeline and the outsourcing of pharmaceutical innovation.
    McMeekin P; Lendrem DW; Lendrem BC; Pratt AG; Peck R; Isaacs JD; Jones D
    Drug Discov Today; 2020 Mar; 25(3):480-484. PubMed ID: 31835019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New vaccine coalition targets epidemics.
    Mullard A
    Nat Rev Drug Discov; 2016 Sep; 15(10):669. PubMed ID: 27681786
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceutical sciences in 2020.
    Crommelin D; Stolk P; Besançon L; Shah V; Midha K; Leufkens H
    Nat Rev Drug Discov; 2010 Feb; 9(2):99-100. PubMed ID: 20118959
    [No Abstract]   [Full Text] [Related]  

  • 10. Traditional drug-discovery model ripe for reform.
    Cressey D
    Nature; 2011 Mar; 471(7336):17-8. PubMed ID: 21368796
    [No Abstract]   [Full Text] [Related]  

  • 11. Open innovation networks between academia and industry: an imperative for breakthrough therapies.
    Melese T; Lin SM; Chang JL; Cohen NH
    Nat Med; 2009 May; 15(5):502-7. PubMed ID: 19424212
    [No Abstract]   [Full Text] [Related]  

  • 12. Building a new biomedical ecosystem: Pfizer's Centers for Therapeutic Innovation.
    Patel AC; Coyle AJ
    Clin Pharmacol Ther; 2013 Sep; 94(3):314-6. PubMed ID: 23645247
    [No Abstract]   [Full Text] [Related]  

  • 13. The creation of innovation through public-private collaboration.
    Esteve M; Ysa T; Longo F
    Rev Esp Cardiol (Engl Ed); 2012 Sep; 65(9):835-42. PubMed ID: 22771082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How can innovative forms of clinical research contribute to deliver affordable cancer care in an evolving health care environment?
    Burock S; Meunier F; Lacombe D
    Eur J Cancer; 2013 Sep; 49(13):2777-83. PubMed ID: 23777742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The innovative medicines initiative: a case study for new ways of working in drug R&D.
    Laverty H; Goldman M
    Future Med Chem; 2014 Apr; 6(5):489-91. PubMed ID: 24649951
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug patent plan gets mixed reviews.
    Butler D
    Nature; 2009 Feb; 457(7233):1064. PubMed ID: 19256077
    [No Abstract]   [Full Text] [Related]  

  • 17. [The RARE 2017 meeting for companies developing products for rare patients].
    Ferry A
    Med Sci (Paris); 2018 May; 34 Hors série n°1():7. PubMed ID: 29911542
    [No Abstract]   [Full Text] [Related]  

  • 18. Crowd-sourcing delivery system innovation: A public-private solution.
    Agrawal S; Chen C; Tanio CP
    Healthc (Amst); 2015 Mar; 3(1):2-4. PubMed ID: 26179583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To the G20: incentivising antibacterial research and development.
    Årdal C; Baraldi E; Ciabuschi F; Outterson K; Rex JH; Piddock LJV; Findlay D;
    Lancet Infect Dis; 2017 Aug; 17(8):799-801. PubMed ID: 28689703
    [No Abstract]   [Full Text] [Related]  

  • 20. The Innovative Medicines Initiative: an engine for regulatory science.
    Goldman M; Seigneuret N; Eichler HG
    Nat Rev Drug Discov; 2015 Jan; 14(1):1-2. PubMed ID: 25503331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.